Usefulness of a new immuno-radiometric assay to detect hepatitis C core antigen in a community-based population

Journal of Viral Hepatitis

Volumn 12, Issue 1, 2005, Pages 106-110

  Hayashi, Katsuhiro ^a,f   Hasuike, S ^a   Kusumoto, K ^a   Ido, A ^b   Uto, H ^a   Kenji, N ^a   Kohara, M ^c   Stuver, S O ^d,e   Tsubouchi, H ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f NONE   (Japan)

Author keywords

Community based population; Hepatitis C virus core antigen; Immuno radiometric assay; Serological hepatitis C virus group

Indexed keywords

HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; HEPATITIS C CORE ANTIGEN; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; IMMUNORADIOMETRIC ASSAY; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERUM;

FEMALE; HEPATITIS C ANTIGENS; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL CORE PROTEINS;

EID: 13244295655     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00558.x     Document Type: Article

References (16)

1. Tanaka T, Lau JYN, Mizokami M et al. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J Hepatol 1995; 23: 742-745.
2. Dickson RC, Mizokami M, Orito E, Qian KP, Lau JY. Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C - clinical and virologic implications. Transplantation 1999; 68: 1512-1516.
3. Komatsu F, Takahashi K. Determination of serum hepatitis C (HCV) core protein using a novel approach for quantitative evaluation of HCV viremia in anti-HCV-positive patients. Liver 1999; 19: 375-380.
4. Widell A, Molnegren V, Pieksma F, Calmann M, Peterson J, Lee SR. Detection of hepatitis C core antigen in serum or plasma as a marker of hepatitis C viremia in the serological window-phase. Transfusion 2002; 12: 107-113.
5. Aoyagi K, Ohue C, Iida K et al. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol 1999; 37: 1802-1808.
6. Tsukiyama-Kohara K, Yamaguchi K, Maki N et al. Antigenicities of grouping I and II hepatitis C virus polypeptides - molecular basis of diagnosis. Virology 1993; 192: 430-437.
7. Ohno T, Mizokami M, Wu RR et al. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. J Clin Microbiol 1997; 35: 201-207.
8. Takahashi K, Okamoto H, Kishimoto S et al. Demonstration of a hepatitis C virus-specific antigen predicted from the putative core gene in the circulation of infected hosts. J Gen Virol 1992; 73: 667-672.
9. Kashiwakuma T, Hasegawa A, Kajita T et al. Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA). J Immunol Methods 1996; 190: 79-89.
10. Bouvier-Alias M, Patel K, Dahari H et al. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatol 2002; 36: 211-218.
11. Tokita H, Kaufman G, Matsubayashi M et al. Hepatitis C virus core mutations reduce the sensitivity of a fluorescence enzyme immunoassay. J Clin Microbiol 2000; 38: 3450-3452.
12. Onto E, Mizokami M, Tanaka T et al. Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes. Gut 1996; 39: 876-880.
13. Tanaka E, Ohue C, Aoyagi K et al. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology 2000; 32: 388-393.
14. Willems M, Moshage H, Nevens F, Fevery J, Yap SH. Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay. J Virol Methods 1993; 42: 127-130.
15. Davis GL, Lau YYN, Urdea MS et al. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method; detection of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994; 19: 1337-1341.
16. Hawkins A, Davidson F, Simmonds P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotype 1, 2, and 3 by Quantiplex HCV assay versions 1 and 2, Roche Monitor assay, and in-house limiting dilution methods. J Clin Microbiol 1997; 35: 187-192.